SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-11-040451
Filing Date
2011-02-18
Accepted
2011-02-18 17:07:42
Documents
2
Group Members
MIDDLETON, MCNEIL, MILLS & ASSOCIATES, VI, LLCSANDERLING VENTURE PARTNERS VI CO- INVESTMENT FUND, L.P.SANDERLING VENTURE PARTNERS VI, L.P.SANDERLING VENTURES MANAGEMENT VISANDERLING VI BETEILIGUNGS GMBH & CO. KGSANDERLING VI LIMITED PARTNERSHIP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D dsc13d.htm SC 13D 148906
2 JOINT FILING AGREEMENT dex991.htm EX-99.1 3974
  Complete submission text file 0001193125-11-040451.txt   155079
Mailing Address 400 SOUTH EL CAMINO REAL STE 1200 SAN MATEO CA 94402-1708
Business Address
MIDDLETON FRED A (Filed by) CIK: 0001267959 (see all company filings)

Type: SC 13D

Mailing Address 5 SYLVAN WAY SUITE 125 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 125 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Subject) CIK: 0001396814 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-86096 | Film No.: 11625321
SIC: 2834 Pharmaceutical Preparations